BiAbs target both CD3 expressed on the surface of T cells and a tumor antigen such as BCMA, expressed on the surface of MM cells, thus mediating T cell activation and subsequent cell death [7]. The gene discussed is TNFRSF17; the disease is Miyoshi myopathy.